Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-24-002738)

Filing Details

Accession Number:: 0001127602-24-002738
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-01-31 16:23:50
Reporting Period:: 2024-01-29

Accepted Time:: 2024-01-31 16:23:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492422	Apellis Pharmaceuticals Inc.	APLS	Pharmaceutical Preparations (2834)	271537290

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1827326	Jeffrey Eisele	C/O Apellis Pharmaceuticals, Inc. 100 Fifth Avenue, 3Rd Floor Waltham MA 02451	Chief Development Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-01-29	279	$64.14	58,179	No	4	S	Direct
Common Stock	Disposition	2024-01-30	971	$65.53	57,208	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/26/2024.
This is a scheduled sale from an established 10b5-1 plan.